United Kingdom

People: Sinopharm Group Co Ltd (1099.HK)

1099.HK on Hong Kong Stock

19 Aug 2019
Change (% chg)

HK$0.40 (+1.50%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Yu, Qingming 

Mr. Yu Qingming serves as Executive Director of the company. He has been working in the pharmaceutical industry for 31 years, with experience in the management of pharmaceuticals, health products and medical devices and holds the professional title of senior engineer. Mr. Yu graduated from Shanghai Medical Equipment College (now known as University of Shanghai for Science and Technology) in 1987, and graduated from the Central Party School majoring in Economic Management in 2001. From July 1987 to April 1990, Mr. Yu successively served as Secretary of Communist League Branch at Beijing Pharmaceutical Station of China National Pharmaceutical Group Co., Ltd., Secretary to the General Manager and Secretary to the Administrative Party Branch of China Medical Instrument Corporation. From April 1990 to February 1997, he served in the State Pharmaceutical Administration, serving as Deputy Director, Chief Director and Department Secretary of the General Office. From February 1997 to December 2009, he successively served as Deputy General Manager of the China Sales Department and Manager of the Corporate Management Department, Assistant to Chairman, Vice President and Executive President of Zhuhai United Laboratories Co., Ltd. and Executive President of Federal Pharmaceutical International Holdings Limited. Mr. Yu was the Director, General Manager and Party Secretary of China Medical Instrument Corporation from December 2009 to August 2010. Since August 2010, Mr. Yu has been in a senior management position of China National Scientific Instruments and Materials Co., Ltd. and China National Medical Device Co., Ltd. Since November 2016, he served as Chairman and Party Secretary of China National Scientific Instruments and Materials Co., Ltd. and China National Medical Device Co., Ltd.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Zhiming Li


Yong Liu


Qiyu Chen


Xiuchang Jiang


Maisong Cai


Jun Lu

As Of  31 Dec 2017